Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
U Deniz DincerDepartment of Pharmacology, Ufuk University School of Medicine. Mevlana Bulvari, Balgat, Ankara, TurkeyAbstract: Metabolic syndrome is characterized by a combination of obesity, hypertension, insulin resistance, dyslipidemia, and impaired glucose tolerance. This multifaceted syndrome i...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-04-01
|
| Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
| Online Access: | http://www.dovepress.com/cardiac-ryanodine-receptor-in-metabolic-syndrome-is-jtv519-k201-future-a9641 |